drugset
drugset / Trial / NCT05648058

Role of Nefopam in Rituximab Transfusion Reaction

NCT05648058 ↗

Phase 3 Unknown 100 enrolled Ministry Of Health / Nineveh Health Directorate
RandomizedParallel-groupDouble-blindTreatment

Summary

the patients will be taken nefopam ampule 50 mg before rituximab in the first group while the second group will be taken diphenhydramine ampule 10 mg before rituximab in the second group

Timeline

Start
2022-12-20
Primary completion
2023-10-20
Completion
2023-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diphenhydramine Unknown 10 mg Intravenous
Subject Nefopam Small molecule 50 mg Intravenous

Indications

No indication recorded.